ZAGATTI, Barbara
 Distribuzione geografica
Continente #
NA - Nord America 3.115
AS - Asia 1.454
EU - Europa 999
SA - Sud America 189
AF - Africa 32
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.790
Nazione #
US - Stati Uniti d'America 3.057
SG - Singapore 542
CN - Cina 355
IT - Italia 197
VN - Vietnam 182
PL - Polonia 157
BR - Brasile 147
DE - Germania 145
GB - Regno Unito 99
HK - Hong Kong 94
UA - Ucraina 94
TR - Turchia 92
FI - Finlandia 76
SE - Svezia 68
FR - Francia 44
IN - India 36
BD - Bangladesh 35
CA - Canada 31
JP - Giappone 28
ID - Indonesia 26
MX - Messico 23
RU - Federazione Russa 23
RO - Romania 21
ES - Italia 18
NL - Olanda 17
AR - Argentina 14
UZ - Uzbekistan 9
ZA - Sudafrica 9
CO - Colombia 8
IQ - Iraq 8
LT - Lituania 8
AT - Austria 7
BE - Belgio 7
PK - Pakistan 6
SA - Arabia Saudita 6
EG - Egitto 5
IR - Iran 5
KE - Kenya 5
DZ - Algeria 4
EC - Ecuador 4
MY - Malesia 4
VE - Venezuela 4
BO - Bolivia 3
CL - Cile 3
IE - Irlanda 3
LB - Libano 3
NP - Nepal 3
TN - Tunisia 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BN - Brunei Darussalam 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GR - Grecia 2
HN - Honduras 2
HR - Croazia 2
MA - Marocco 2
NO - Norvegia 2
OM - Oman 2
PE - Perù 2
BH - Bahrain 1
GY - Guiana 1
HU - Ungheria 1
IL - Israele 1
JO - Giordania 1
KG - Kirghizistan 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
NG - Nigeria 1
PH - Filippine 1
PY - Paraguay 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SR - Suriname 1
TH - Thailandia 1
TL - Timor Orientale 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.790
Città #
Ashburn 389
Singapore 321
Fairfield 290
San Jose 242
Houston 200
Woodbridge 193
Warsaw 155
Chandler 148
Ann Arbor 132
Beijing 128
Santa Clara 115
Seattle 115
Jacksonville 108
Wilmington 104
Cambridge 88
Hong Kong 88
Ho Chi Minh City 68
Los Angeles 68
New York 66
Ferrara 62
Munich 58
Dallas 57
Izmir 49
Milan 41
Hanoi 39
Nanjing 35
Helsinki 27
Shanghai 27
Tokyo 27
Turku 27
Princeton 25
Jakarta 22
Lauterbourg 22
Boardman 20
London 20
Orem 20
São Paulo 20
San Diego 19
Timisoara 17
Atlanta 14
Buffalo 14
Nanchang 13
Rome 13
Chicago 12
The Dalles 12
Bremen 11
Brooklyn 11
Changsha 11
Council Bluffs 11
Falls Church 11
Mexico City 11
Shenyang 11
Denver 10
Manchester 10
Montreal 10
Stockholm 10
Toronto 10
Dong Ket 9
Addison 8
Chennai 8
Hebei 8
Poplar 8
San Francisco 8
Brussels 7
Dearborn 7
Frankfurt am Main 7
Querétaro 7
Rio de Janeiro 7
Ankara 6
Augusta 6
Cleveland 6
Da Nang 6
Guangzhou 6
Haiphong 6
Jiaxing 6
Orange 6
Phoenix 6
Tashkent 6
Tianjin 6
Baghdad 5
Bologna 5
Boston 5
Guarulhos 5
Johannesburg 5
Madrid 5
Mountain View 5
Mumbai 5
Nairobi 5
Paris 5
Somerville 5
Auburn Hills 4
Hangzhou 4
Hyderabad 4
Kunming 4
Maceió 4
Moscow 4
Naples 4
Ningbo 4
Nuremberg 4
Piscataway 4
Totale 4.102
Nome #
Absolute quantification of cell-free microRNAs in cancer patients 333
MicroRNA expression profiling identifies miR-31-5p/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab 312
MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer 301
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 291
miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model 266
MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin 258
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 251
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression 243
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 241
microRNAome Expression in Chronic Lymphocytic Leukemia: Comparison with Normal B-cell Subsets and Correlations with Prognostic and Clinical Parameters 237
Characterisation of peripheral blood mononuclear cell microRNA in early onset psoriatic arthritis 232
Investigations on microRNAs in human chronic lymphocytic leukemia and control of cancer-associated molecular pathways 230
Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia 215
Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma 215
Altered miRNA expression in T regulatory cells in course of multiple sclerosis 210
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 207
miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eµ-TCL1 mouse model 202
Clinical Monoclonal B lymphocytosis versus Rai 0 Chronic Lymphocytic Leukemia: a Comparison of Cellular, Cytogenetic, Molecular, and Clinical Features 194
EPIGENETIC CHANGES AT CHROMOSOME REGION 11p15.5 IN HUMAN CANCER 188
MiR-145 participates with TP53 in a death promoting regulatory loop and targets estrogen receptor in human breast cancer cells 184
MicroRNA expression profile in peripheral blood cells of psoriatic arthritis 181
Altered miRNA expression in T regulatory cells in course of multipla sclerosis 180
KVDMR1, A LOCUS FREQUENTLY HYPOMETHYLATED IN HUMAN CANCER, IS A STRONG ENHANCER-PROMOTER ELEMENT FOR THE EXPRESSION OF LIT1, AN UNTRANSLATED IMPRINTOR GENE AT CHROMOSOME 11p15.5. 168
miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs 128
How to fish a good micro-marker out from a worthless lake: The case of cell-free miR-181a-5p and breast cancer 119
null 109
null 89
null 77
Totale 5.861
Categoria #
all - tutte 23.484
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.484


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202152 0 0 0 0 0 0 0 0 0 0 0 52
2021/2022347 13 30 35 14 23 16 23 26 6 23 41 97
2022/2023311 30 35 5 54 39 48 26 21 37 1 6 9
2023/2024198 15 24 9 3 15 42 11 12 5 13 0 49
2024/2025849 17 15 59 51 99 70 30 12 169 68 115 144
2025/20262.193 237 55 151 301 333 165 348 114 186 162 121 20
Totale 5.861